Spexin, the recently identified peptide that is closely related to the pathogenesis of glucose and lipid metabolism-related dis-eases, including obesity, diabetes and non-alcoholic fatty liver diseases, can suppress the bile acid synthesis and play physiological functions on bile acid metabolism [11]. Here, SPX is linked to metabolic dysfunction-associated steatotic liver disease.